t 0632 has been researched along with gabexate in 1 studies
Studies (t 0632) | Trials (t 0632) | Recent Studies (post-2010) (t 0632) | Studies (gabexate) | Trials (gabexate) | Recent Studies (post-2010) (gabexate) |
---|---|---|---|---|---|
6 | 0 | 1 | 743 | 53 | 106 |
Protein | Taxonomy | t 0632 (IC50) | gabexate (IC50) |
---|---|---|---|
Solute carrier family 22 member 2 | Homo sapiens (human) | 0.9 | |
Coagulation factor X | Homo sapiens (human) | 4.61 | |
Plasminogen | Homo sapiens (human) | 0.431 | |
Urokinase-type plasminogen activator | Homo sapiens (human) | 0.431 | |
Serine protease hepsin | Homo sapiens (human) | 0.383 | |
Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 0.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Endo, T; Kume, E; Nagasaki, M; Shikano, T; Taniguchi, H; Yomota, E | 1 |
1 other study(ies) available for t 0632 and gabexate
Article | Year |
---|---|
Effect of T-0632, a cholecystokininA receptor antagonist, on experimental acute pancreatitis.
Topics: Acute Disease; Amylases; Animals; Ceruletide; Disease Models, Animal; Dogs; Esters; Female; Gabexate; Guanidines; Hormone Antagonists; Indoles; Ligation; Male; Pancreatic Ducts; Pancreatitis; Proglumide; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptor, Cholecystokinin A; Receptors, Cholecystokinin | 1997 |